Prenatal Diagnosis

Prenatal Diagnosis is the official journal of ISPD. Published online 12 to 13 times per year, this peer-reviewed publication communicates the results of clinical and basic research in prenatal and preimplantation diagnosis in humans, animal and in vitro models.

All ISPD members receive an online subscription to Prenatal Diagnosis as part of their membership. Print subscriptions are available only to institutions. General information is available on the Journal home page on the publisher's website.

Full Access for ISPD Members

Not a member? Review the benefits of ISPD membership.

Manuscript Submission

All manuscripts should be submitted on the publisher's website. Submission instructions and contact information are on the Author Resources tab of the journal home page. Articles are reviewed by the Editorial Board and invited peer reviewers.

Upcoming Special Topic Issue — Read the full call for papers:
Fetal Cardiology (deadline 31 Dec 2023)


Journal Article Submission

Recent Issues

The Editor's Choice articles of Prenatal Diagnosis are open access. For access to all articles, please use the member journal access.

Volume 43 | Issue 12 | November 2023

Table of Contents

Editor's Choice Article:

Brewer CJ, Makhamreh MM, Shivashankar K, et al. PIEZO1 is the most common monogenic etiology of non-immune hydrops fetalis detected by prenatal exome sequencing.
DOI: 10.1002/pd.6451

Volume 43 | Issue 11 | October 2023

Table of Contents

Editor's Choice Article:
Gai W, Yu SCY, Chan WTC, et al. Droplet digital PCR is a cost‐effective method for analyzing long cell‐free DNA in maternal plasma: Application in preeclampsia.
DOI: 10.1002/pd.6432

Volume 43 | Issue 4 | April 2023

Special Topic Issue | Highlights of the 26th ISPD annual conference in Montréal (full length articles)

Table of Contents

Abstract Issues

International Conference on Prenatal Diagnosis and Therapy, from 2010 on

Volume 43, Issue S1 — Montréal 2022

See All Abstract Issues


Aims & Scope

Prenatal Diagnosis welcomes submissions in all aspects of prenatal screening and diagnosis with a particular focus on areas in which molecular biology and genetics interface with prenatal care and therapy, encompassing:

  • prenatal molecular genetics, including genome sequencing and the diagnosis of single gene disorders
  • fetal therapy
  • fetal and placental cell-free nucleic acids and cells in maternal blood and other fluids
  • fetal imaging in relation to congenital anomalies, genetic syndromes and fetal phenotyping
  • prenatal cytogenetics and cytogenomics
  • prenatal and preconceptional genetic screening and counseling 
  • fetal and placental transcriptome, proteome and metabolome studies
  • development and evaluation of laboratory services for prenatal testing
  • psychosocial, legal, ethical and economic aspects of prenatal testing and fetal treatments
  • fetal and placental development and pathology 
  • preimplantation genetic testing (PGT)

The overriding criteria for publication are scientific merit, originality, and interest to a multidisciplinary audience.